About the Series |
|
iii | |
|
Preface |
|
ix | |
Contributors |
|
xix | |
|
Cosmetic Formulation of Skin Care Products |
|
|
1 | (2) |
|
|
Introduction: How to Utilize This Text |
|
|
1 | (2) |
|
PART I: CUTANEOUS FORMULATION ISSUES |
|
|
|
Cutaneous Formulation Issues |
|
|
3 | (24) |
|
|
Site-Specific Cutaneous Needs |
|
|
3 | (23) |
|
|
26 | (1) |
|
Formulation for Special Populations |
|
|
27 | (8) |
|
|
|
27 | (1) |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
31 | (1) |
|
Contact Dermatitis Issues |
|
|
32 | (2) |
|
|
34 | (1) |
|
|
34 | (1) |
|
|
34 | (1) |
|
PART II: FORMULATION DEVELOPMENT AND APPLICATION |
|
|
|
Personal Cleansing Products: Properties and Use |
|
|
35 | (32) |
|
|
|
35 | (1) |
|
|
35 | (5) |
|
Personal Cleanser Effects on Skin |
|
|
40 | (14) |
|
Some Practical Considerations When Choosing a Personal Cleanser |
|
|
54 | (5) |
|
|
59 | (8) |
|
|
67 | (12) |
|
|
|
67 | (1) |
|
|
67 | (1) |
|
Function and Order of Application Within a Skin Care Regimen |
|
|
68 | (1) |
|
Formulation Considerations |
|
|
68 | (5) |
|
|
73 | (1) |
|
|
74 | (1) |
|
|
74 | (1) |
|
|
75 | (1) |
|
|
75 | (1) |
|
|
76 | (3) |
|
|
79 | (36) |
|
|
|
|
79 | (1) |
|
Stratum Corneum and Epidermal Structure |
|
|
80 | (1) |
|
Stratum Corneum Lipid Chemistry and Biophysics |
|
|
81 | (3) |
|
Stratum Corneum Corneodesmosomes and Corneodesmolysis |
|
|
84 | (3) |
|
Corneocyte Envelope Maturation and the Role of Transglutaminases |
|
|
87 | (2) |
|
Stratum Corneum Natural Moisturizing Factors (NMF) |
|
|
89 | (3) |
|
The Effect of Humidity on Epidermal Differentiation and Stratum Corneum Quality |
|
|
92 | (1) |
|
The Pathophysiology of Winter-and Soap-Induced Dry Skin |
|
|
93 | (3) |
|
The ``Dry Skin Cvcle'' Model: A New Wav to Describe Induction and Propagation of the Xerosis |
|
|
96 | (3) |
|
|
99 | (7) |
|
|
106 | (1) |
|
|
107 | (8) |
|
Factors Influencing Optimal Skin Care and Product Selection |
|
|
115 | (8) |
|
|
Basic Skin Care Processes |
|
|
115 | (1) |
|
The Epidermal Barrier and Water Content |
|
|
116 | (1) |
|
Epidermal Barrier Integrity, Function, and Repair |
|
|
117 | (1) |
|
Impact of Exogenous Moisturization on Barrier Repair |
|
|
117 | (1) |
|
Clinical Implications of Exogenous Moisturization |
|
|
117 | (1) |
|
Components of Moisturizer Formulations |
|
|
118 | (1) |
|
Balancing Effects and Cosmetic Elegance of Product Components |
|
|
118 | (1) |
|
Formulation Characteristics |
|
|
119 | (1) |
|
Special Additives and Ingredients |
|
|
119 | (1) |
|
The Significance of Gentle Skin Cleansing |
|
|
120 | (1) |
|
Basic Cleanser Formulations |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
121 | (2) |
|
|
123 | (12) |
|
|
|
|
|
123 | (1) |
|
|
124 | (2) |
|
|
126 | (2) |
|
|
128 | (3) |
|
Formulating for the Consumer |
|
|
131 | (1) |
|
Introducing New Antiperspirant Active Formulations |
|
|
131 | (1) |
|
Medical Approaches to Hyperhidrosis |
|
|
131 | (3) |
|
|
134 | (1) |
|
PART III: ACTIVE INGREDIENTS FOR SKIN TREATMENT |
|
|
|
|
135 | (18) |
|
|
|
|
135 | (1) |
|
|
136 | (5) |
|
|
141 | (2) |
|
|
143 | (1) |
|
|
144 | (1) |
|
|
145 | (3) |
|
|
148 | (1) |
|
|
149 | (4) |
|
Photoprotection and the Prevention of Photocarcinogenesis |
|
|
153 | (14) |
|
|
|
|
153 | (1) |
|
Relationship of UV Exposure to Skin Cancer Development |
|
|
154 | (1) |
|
Spectral Differences Related to UV Photocarcinogenesis |
|
|
155 | (1) |
|
Photocarcinogenesis-Decreasing Photoprotection Modalities |
|
|
155 | (1) |
|
|
156 | (1) |
|
Types of Sunscreens and Mechanisms of Action |
|
|
156 | (1) |
|
|
157 | (2) |
|
|
159 | (1) |
|
Photocarcinogenesis Reduction by Wearing Clothing |
|
|
159 | (1) |
|
|
160 | (1) |
|
Effectiveness of Photoprotection |
|
|
160 | (1) |
|
Photoprotection and Vitamin D |
|
|
160 | (1) |
|
Patient Recommendations and Future Directions |
|
|
161 | (1) |
|
|
162 | (5) |
|
Anti-aging Skin Care Formulations |
|
|
167 | (20) |
|
|
|
167 | (1) |
|
|
167 | (3) |
|
|
170 | (4) |
|
|
174 | (2) |
|
|
176 | (2) |
|
Dimethylaminoethanol (DMAE) |
|
|
178 | (1) |
|
Kinetion (N6-Furfuryladenine) |
|
|
179 | (1) |
|
|
180 | (1) |
|
Ubiquinone (Co-Enzyme Q10) |
|
|
181 | (1) |
|
|
181 | (1) |
|
|
181 | (2) |
|
|
183 | (4) |
|
The Role of Cosmeceuticals in Dermatology |
|
|
187 | (18) |
|
|
|
|
What Are ``Cosmeceuticals''---Cosmetics vs. RX Drugs |
|
|
187 | (4) |
|
Domestic and International Regulatory Guidelines Impacting Cosmetics |
|
|
191 | (1) |
|
Categories of Currently Popular Cosmeceuticals in Dermatology |
|
|
192 | (7) |
|
How to Select the ``Best'' Formulation of a Cosmeceutical |
|
|
199 | (1) |
|
The Future of Cosmeceuticals |
|
|
200 | (2) |
|
|
202 | (3) |
|
|
205 | (14) |
|
|
|
|
205 | (4) |
|
Product Reduction and Reactive Oxygen Species |
|
|
209 | (2) |
|
Inhibition of Melanosome Transfer |
|
|
211 | (1) |
|
Skin Turnover Acceleration |
|
|
212 | (1) |
|
Traditional Chinese Medicine |
|
|
213 | (2) |
|
|
215 | (4) |
|
Medical and Surgical Approaches to Skin Lightening |
|
|
219 | (18) |
|
|
|
|
219 | (2) |
|
Topical Depigmenting Agents |
|
|
221 | (1) |
|
Phenolic Depigmenting Agents |
|
|
221 | (3) |
|
|
224 | (1) |
|
|
225 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
227 | (1) |
|
|
228 | (1) |
|
|
228 | (1) |
|
|
228 | (2) |
|
|
230 | (1) |
|
|
231 | (1) |
|
|
232 | (5) |
|
Topical Exfoliation---Clinical Effects and Formulating Considerations |
|
|
237 | (14) |
|
|
|
|
237 | (1) |
|
Physical Exfoliants: Scratching the Surface |
|
|
238 | (1) |
|
|
239 | (8) |
|
|
247 | (1) |
|
|
247 | (4) |
|
Over-the-Counter Acne Medications |
|
|
251 | (22) |
|
|
|
|
251 | (1) |
|
|
252 | (1) |
|
Highlights of Over-the-Counter Acne Monograph |
|
|
253 | (1) |
|
Formulation of Over-the-Counter Acne Products |
|
|
253 | (1) |
|
Trends in Over-the-Counter Acne Formulations |
|
|
254 | (1) |
|
Advances in Over-the-Counter Acne Formulations |
|
|
255 | (12) |
|
|
267 | (1) |
|
|
268 | (5) |
|
Acne Treatment Methodologies |
|
|
273 | (24) |
|
|
|
|
|
273 | (3) |
|
|
276 | (1) |
|
|
276 | (3) |
|
|
279 | (1) |
|
|
279 | (2) |
|
|
281 | (1) |
|
|
281 | (1) |
|
|
281 | (5) |
|
|
286 | (1) |
|
|
287 | (3) |
|
|
290 | (1) |
|
|
291 | (1) |
|
|
292 | (5) |
|
|
297 | (12) |
|
|
|
|
297 | (1) |
|
|
298 | (1) |
|
|
298 | (1) |
|
Accurate Identification of Plant Species |
|
|
299 | (1) |
|
Harvesting Plant Material |
|
|
299 | (1) |
|
|
300 | (2) |
|
Standardization of Extracts |
|
|
302 | (1) |
|
|
303 | (1) |
|
|
304 | (1) |
|
|
305 | (1) |
|
|
305 | (4) |
|
Herbs in Cosmeceuticals: Are They Safe and Effective? |
|
|
309 | (42) |
|
|
|
309 | (1) |
|
|
310 | (1) |
|
|
311 | (1) |
|
|
311 | (17) |
|
|
328 | (19) |
|
|
347 | (1) |
|
|
347 | (4) |
|
Topical Anti-inflammatories |
|
|
351 | (26) |
|
|
|
|
351 | (1) |
|
Biology of Skin Inflammation |
|
|
351 | (2) |
|
Prescription and Over-the-Counter Treatments for Inflammation and Mechanism of Action |
|
|
353 | (8) |
|
Anti-inflammatory Cosmeceutical ``Actives'' |
|
|
361 | (2) |
|
Biological Screening Assays to Identify Novel Anti-inflammatory Compounds |
|
|
363 | (5) |
|
Development of Effective Topical Formulations |
|
|
368 | (5) |
|
|
373 | (1) |
|
|
373 | (4) |
|
Topical Nutritional Antioxidants |
|
|
377 | (26) |
|
|
|
377 | (1) |
|
|
377 | (2) |
|
|
379 | (5) |
|
|
384 | (2) |
|
New Combinations of Antioxidants |
|
|
386 | (1) |
|
|
387 | (3) |
|
|
390 | (4) |
|
|
394 | (1) |
|
|
395 | (1) |
|
|
396 | (7) |
|
What Is Next in Skin Care Cosmetic Products? |
|
|
403 | (6) |
|
|
|
403 | (2) |
|
|
405 | (1) |
|
|
405 | (1) |
|
|
406 | (1) |
|
|
406 | (1) |
|
|
407 | (1) |
|
|
407 | (1) |
|
|
407 | (1) |
|
|
408 | (1) |
Index |
|
409 | |